Lung Cancer Attracts Greater Stigma than Other Cancer Types in Aotearoa New Zealand

Background. Lung cancer is the leading cause of cancer death in Aotearoa New Zealand, killing over 1,700 people each year. Despite the burden of lung cancer in Aotearoa New Zealand, the popular press has referred to it as the cancer type that no one talks about. Here, we investigate one factor that...

Full description

Saved in:
Bibliographic Details
Published in:Journal of oncology 2022-08, Vol.2022, p.2183055-6
Main Authors: Godward, Jess, Riordan, Benjamin C., Winter, Taylor, Ashton, John C., Hunter, John, Scarf, Damian
Format: Article
Language:English
Subjects:
Acquired immune deficiency syndrome
AIDS
Analysis
Cancer
Cervical cancer
Diagnosis
Discrimination
Empathy
Ethnicity
Females
Funding
Health aspects
HIV
Human immunodeficiency virus
Immune system
Lung cancer
Medical research
Skin cancer
Social networks
Stigma
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. Lung cancer is the leading cause of cancer death in Aotearoa New Zealand, killing over 1,700 people each year. Despite the burden of lung cancer in Aotearoa New Zealand, the popular press has referred to it as the cancer type that no one talks about. Here, we investigate one factor that may contribute to this state of affairs: lung cancer stigma. Methods. Participants were university students and members of the general public. University students were recruited via an online experiment participation system in 2021. Members of the public were recruited via social media. All participants completed the Cancer Stigma Scale (CSS) for one of five cancer types (lung, cervical, breast, skin, or bowel). The CSS is a 25-item scale with six subscales: awkwardness, avoidance, severity, policy opposition, personal responsibility, and financial discrimination. Results. The mean age of participants was 24.3 (Standard Deviation = 10.4). Data from each subscale were submitted to an analysis of covariance (ANCOVA), with cancer type as a between-participant factor (5: lung, cervical, breast, skin, or bowel) and stigma as the dependent variable. Relative to most other cancer types, people were more likely to avoid someone with lung cancer, view interacting with someone with lung cancer as more awkward, and view people with lung cancer as being responsible for their condition. Conclusion. The Health Research Council of New Zealand recently funded the very first trial of lung cancer screening in Aotearoa New Zealand. The current study suggests that addressing stigma will be essential for the success of such programs, with stigma likely influencing those who engage in such trials.
ISSN:1687-8450
1687-8450
DOI:10.1155/2022/2183055